Express Scripts Holding Company (NASDAQ:ESRX) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $6.95-7.05 for the period, compared to the Thomson Reuters consensus estimate of $6.97. Express Scripts Holding also updated its Q3 guidance to $1.88-1.92 EPS.
A number of brokerages recently commented on ESRX. Bank of America Corporation reiterated a neutral rating and set a $77.00 price objective on shares of Express Scripts Holding in a research report on Tuesday, April 25th. Cowen and Company reduced their price objective on Express Scripts Holding from $90.00 to $83.00 and set an outperform rating on the stock in a research report on Tuesday, April 25th. SunTrust Banks, Inc. reissued a buy rating on shares of Express Scripts Holding in a research note on Tuesday, April 25th. Mizuho cut their target price on Express Scripts Holding from $76.00 to $61.00 and set a neutral rating for the company in a research note on Tuesday, April 25th. Finally, UBS AG set a $71.00 target price on Express Scripts Holding and gave the stock a hold rating in a research note on Tuesday, April 25th. Four analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of Hold and an average target price of $70.81.
Express Scripts Holding Company (ESRX) traded down 0.11% during mid-day trading on Friday, hitting $62.53. The stock had a trading volume of 2,848,358 shares. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.61. The company has a 50-day moving average of $63.15 and a 200-day moving average of $64.92. The firm has a market cap of $36.11 billion, a PE ratio of 10.85 and a beta of 0.90.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.57 earnings per share. Analysts expect that Express Scripts Holding Company will post $6.99 earnings per share for the current year.
In other news, VP Phyllis S. Anderson sold 1,100 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the transaction, the vice president now directly owns 11,108 shares in the company, valued at $667,368.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.68% of the stock is owned by insiders.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.
